6 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
are contacts of infectious ... isolate DST result should ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... best prevented by using ... CMV retinitis should ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology #
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... empiric treatment should ... Guidelines for dosing ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
to Table 5 for dosing ... Note: Active TB should ... prevent or delay emergence ... opportunistic #infections ... #HIVAIDS #pharmacology
GRACE-2 Guidelines for Low-Risk, Recurrent Abdominal Pain in the ED

1) Should adult ED patients with low-risk,
in the ED 1) Should ... may be performed during ... non-opioid and/or non-pharmacologic ... #Emergency #diagnosis ... #management